Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) shares reached a new 52-week low on Wednesday . The company traded as low as $13.25 and last traded at $14.26, with a volume of 191012 shares trading hands. The stock had previously closed at $16.29.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on KMTS. Stifel Nicolaus assumed coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They set a "buy" rating and a $28.00 price target for the company. Bank of America initiated coverage on shares of Kestra Medical Technologies in a research note on Monday, March 31st. They issued a "buy" rating and a $30.00 price target for the company. Piper Sandler began coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They issued an "overweight" rating and a $27.00 target price for the company. Wells Fargo & Company lowered their price target on shares of Kestra Medical Technologies from $28.00 to $27.00 and set an "overweight" rating for the company in a report on Thursday. Finally, Wolfe Research started coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They issued an "outperform" rating and a $29.00 target price on the stock. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $27.33.
View Our Latest Report on KMTS
Kestra Medical Technologies Trading Down 3.4%
The company's 50 day simple moving average is $18.89.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Jane Street Group LLC acquired a new position in Kestra Medical Technologies in the 1st quarter valued at about $756,000. Woodline Partners LP acquired a new position in shares of Kestra Medical Technologies in the first quarter valued at about $2,510,000. Yu Fan bought a new position in Kestra Medical Technologies during the first quarter worth about $56,880,000. Zimmer Partners LP acquired a new stake in Kestra Medical Technologies in the 1st quarter worth about $374,000. Finally, Millennium Management LLC bought a new stake in Kestra Medical Technologies in the 1st quarter valued at about $11,036,000.
Kestra Medical Technologies Company Profile
(
Get Free Report)
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Read More
Before you consider Kestra Medical Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kestra Medical Technologies wasn't on the list.
While Kestra Medical Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access